The North America Protein Assays Market is witnessing robust growth fueled by advancements in biotechnology research, increasing investments in pharmaceutical R&D, and the rising prevalence of chronic diseases. The market size was valued at USD 1,195 Million in 2025 and is projected to reach USD 2,880 Million by 2035, at a CAGR of 8.4% between 2024 and 2035. Growing innovation in assay platforms, expanding applications in clinical diagnostics, and the entry of new market players are further accelerating its momentum.
The economic impact of tariffs on "North America Protein Assays Market".
North America Protein Assays Market - Key Growth Drivers
Rising Pharmaceutical & Biotech R&D Expenditure: Increased funding for drug discovery and development across North America is driving the adoption of advanced protein assay solutions. Major biotech companies such as Thermo Fisher Scientific and Bio-Rad Laboratories are enhancing their assay portfolios to meet the demand for reliable protein quantification in various research and clinical applications. The need for precise and high-throughput assays in drug validation is further fueling market expansion.
Expanding Clinical Diagnostic Applications: The growing prevalence of chronic diseases such as cancer, diabetes, and neurodegenerative disorders necessitates innovative diagnostic tools. Protein assays are vital in biomarker discovery and disease monitoring, encouraging hospitals and diagnostic labs to invest in high-sensitivity assay kits. Recent collaborations among companies like Abcam and PerkinElmer with healthcare providers have strengthened the integration of protein assays in routine clinical diagnostics.
North America Protein Assays Market - Latest Trends
Integration of Automation and High-Throughput Technologies: Increasing adoption of automated liquid handling systems and robotic platforms in laboratories is transforming the field of protein assays. Companies such as Thermo Fisher Scientific are launching next-generation automated assay systems that offer greater accuracy, efficiency, and scalability. This trend is enabling researchers to process large-scale samples for drug development and clinical research, minimizing human error and expediting discovery timelines.
Development of Multiplex Assay Formats: There is a growing emphasis on multiplexing capabilities that allow simultaneous quantification of multiple proteins in a single sample. Companies such as Bio-Rad Laboratories and Luminex Corporation are offering multiplex immunoassays that boost laboratory productivity while conserving precious samples. This approach is crucial for biomarker research, translational medicine, and personalized healthcare, supporting comprehensive disease profiling.
North America Protein Assays Market - Market Opportunities
Emergence of Companion Diagnostics: The increasing adoption of personalized medicine encourages development of protein assays as companion diagnostics for targeted therapies. Leading firms, including Roche and Agilent Technologies, are collaborating with pharma companies to create co-developed assays, opening significant revenue streams in oncology and immunology.
Expansion into Untapped Clinical Segments: Opportunities exist to expand protein assay applications within neurology and infectious disease diagnostics. Innovators like Quanterix are actively developing platforms that address these segments, offering potential for new product launches and expanded market share.
North America Protein Assays Market Revenue (USD Million), 2020-2035
The market revenue for the North America Protein Assays Market has demonstrated steady growth from 2020 through 2035. Starting at USD 550 Million in 2020, the market is expected to accelerate, reaching an estimated USD 1,195 Million by 2025. The positive trajectory is anticipated to continue, driven by technological advancements and expanding diagnostic applications, culminating at approximately USD 2,880 Million by 2035. This robust growth is underpinned by sustained industry investment and increasing demand across research and clinical diagnostics, reflecting confidence in protein assay technologies for precision medicine and drug development.
North America Protein Assays Market Share by Region (%), 2025
In 2025, the United States accounts for the lion’s share of the North America Protein Assays Market, representing 72% of total revenue. Canada follows with a substantial 18% share, signifying robust healthcare infrastructure and research activities. Mexico comprises 6%, strengthening its role in the regional market with growing biotech investment. Remaining North American countries collectively account for 4%. These figures highlight the dominance of the U.S. but also acknowledge the rising importance of adjacent markets that are expected to contribute meaningfully to future growth.
North America Protein Assays Market - Recent Developments
In March 2024, Thermo Fisher Scientific launched its advanced Pierce Multiplex Protein Assay, supporting simultaneous quantification of up to 40 proteins per sample. The product is designed for high-throughput clinical and research settings, enhancing data reliability and reducing assay time. This development is expected to strengthen Thermo Fisher’s market position across North America.
In February 2024, Bio-Rad Laboratories expanded its protein assay product line by introducing the Bio-Plex Pro Human Cytokine Screening Panel, catering to the growing demand for robust immune profiling in translational research. The launch enables researchers to detect multiple protein biomarkers efficiently, addressing key needs in oncology and autoimmune disease studies.
In January 2024, Abcam announced a strategic partnership with a leading hospital network to co-develop protein assay solutions for early disease detection. The collaboration aims to integrate high-sensitivity assays into routine clinical workflows, thereby accelerating the adoption of next-generation diagnostics and reinforcing Abcam’s role in personalized healthcare innovation.
Press Releases